Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Active rabies vaccine (US-FDA approved)
Active rabies vaccine · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| KamRAB | EXPERIMENTAL | KamRAB 20 IU/kg body weight via IM injection, once on Day 0 |
| FDA approved HRIG product | ACTIVE_COMPARATOR | Comparator product: Intramuscular (IM) injection once on Day 0 in the same manner and at the same dosage as KamRAB. |
| Name | Type | Description |
|---|---|---|
| Active rabies vaccine (US-FDA approved) | DRUG | A 1.0 ml dose of active vaccine (2.5 IU/ml), will be given on 5 occasions, on Days 0, 3, 7, 14, and 28 On day 0, the day when the HRIG is given, the first vaccine dose could be given within few minutes from the time of HRIG injection was given and never be administered into the same anatomical site as the HRIG. |
Inclusion Criteria: * Able and willing to sign an informed consent. * Healthy male or female subjects of 18 - 75 years of age inclusive who have not previously been immunized against rabies. * Ability to comply with completion of a home diary. * No previous exposure to Rabies epidemic, Rabies vacci...